Credit Suisse Downgrades Galapagos NV (GLPG) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Coursera plans layoffs after Udemy merger, estimates $8M-$11M in costs
Galapagos to advance filgotinib to Phase 3 in rheumatoid arthritis
September 25, 2015 10:49 AM EDTGalapagos regains all unencumbered rights to filgotinib Filgotinib is the most selective JAK1 inhibitor Best-in-class efficacy and safety in RA in 24-week Phase 2B studies in 877 patients Phase 3 start in RA expected in early 2016
MECHELEN, Belgium, Sept. 25, 2015 (GLOBE NEWSWIRE) -- Galapagos to hold a conference call open to the public  today at 17.15 CET/11:15 AM EDT CODE: 830162
UK: +44 330 336 6025 USA: +1 719 325 2556 Belgium:... More